Akums Drugs & Pharmaceuticals Ltd (AKUMS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039335, "name": "Akums Drugs", "stock_name": "Akums Drugs", "full_name": "Akums Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/akums-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "727.25", "chg": -24.35, "chgp": "-3.24%", "dir": -1, "prev_price": "751.60", "mcapval": "11,643.00 Cr", "mcap": "Small Cap", "scripcode": "544222", "symbol": "AKUMS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE09XN01023", "curr_date": "Aug 14, 04:01 PM", "curr_time": "12:53 PM", "last_traded_at": "Aug 14, 04:01 PM IST", "bse_nse_vol": "1.94 lacs", "exc_status": "Active", "traded_date": "Aug 14, 2026", "traded_date_str": "2026 08 14", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akums-drugs-10039335-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Akums Drugs Gains 4.41%: 6 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-gains-441-6-key-factors-driving-the-weeks-momentum-4154976", "imagepath": "", "date": "2026-08-15 10:01:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> New 52-week high at Rs.750</p>\n <p><strong>11 Aug:</strong> All-time high reached at Rs.760.5</p>\n <p><strong>12 Aug:</strong> New 52-week high at Rs.775.45 with slight pullback</p>\n <p><strong>14 Aug:</strong> Downgrade to Hold amid valuation concerns</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.696.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.727.25</div><div class=\"stat-change positive\">+4.41%</di..." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Downgraded to Hold Amid Valuation Concerns Despite Strong Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-downgraded-to-hold-amid-valuation-concerns-despite-strong-financials-4152995", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_mojoScore_4152995.png", "date": "2026-08-14 08:29:48", "description": "Akums Drugs & Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold following a comprehensive reassessment of its quality, valuation, financial trend, and technical parameters. While the company’s recent quarterly financial performance has been robust, elevated valuation metrics and mixed technical signals have tempered enthusiasm among analysts, prompting a more cautious stance." }, { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-buy-4151590", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_mojoScore_4151590.png", "date": "2026-08-13 10:11:31", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 August 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 775.45", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-at-rs77545-4149822", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_priceRelatedfactors_4149822.png", "date": "2026-08-12 09:59:01", "description": "With a 57.24% gain over the past year, Akums Drugs & Pharmaceuticals Ltd has surged to a fresh 52-week high of Rs 775.45 on 12 Aug 2026, outpacing the Sensex which declined by 2.85% over the same period. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 760.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-of-rs7605-4147361", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_priceRelatedfactors_4147361.png", "date": "2026-08-11 10:12:06", "description": "With a decisive break above Rs 760.5 on 11 Aug 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive rally that has delivered 58.48% returns over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices." }, { "title": "Akums Drugs & Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-change-4146284", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_valuationdot_4146284.png", "date": "2026-08-11 08:02:48", "description": "Akums Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a recalibration of price attractiveness amid robust stock performance and evolving market dynamics." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Surges 7.68% to Day's High of Rs 750 — Outperforms Sector by 7.18 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-intraday-high-with-768-surge-4145605", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_priceRelatedfactors_4145605.png", "date": "2026-08-10 11:46:42", "description": "The Sensex edged up 0.09% on 10 Aug 2026, but Akums Drugs & Pharmaceuticals Ltd outpaced the broader market with a robust 7.68% gain, reaching an intraday high of Rs 750. This 7.18 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 750", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-at-rs750-4145485", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_priceRelatedfactors_4145485.png", "date": "2026-08-10 10:18:31", "description": "Surging past its previous peak, Akums Drugs & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 750 on 10 Aug 2026, marking a remarkable 53.0% gain over the past year and outpacing the Sensex’s modest decline of 1.72% during the same period." }, { "title": "When is the next results date for Akums Drugs & Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-akums-drugs-pharmaceuticals-ltd-4140709", "imagepath": "", "date": "2026-08-06 23:20:53", "description": "The next results date for Akums Drugs & Pharmaceuticals Ltd is scheduled for August 8, 2026...." } ], "total": 237, "sid": "10039335", "stock_news_url": "https://www.marketsmojo.com/news/akums-drugs-pharmaceuticals-10039335" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "13-Aug-2026", "details": "Transcript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "13-Aug-2026", "details": "Intimation of Schedule of the Investors/Analysts Meet", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "10-Aug-2026", "details": "Intimation of Schedule of the Investors/Analysts Meet to be held on August 14 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Akums Drugs & Pharmaceuticals Ltd has declared <strong>50%</strong> dividend, ex-date: 03 Jul 26", "dt": "2026-07-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

10 Aug: New 52-week high at Rs.750

11 Aug: All-time high reached at Rs.760.5

12 Aug: New 52-week high at Rs.775.45 with slight pullback

14 Aug: Downgrade to Hold amid valuation concerns

+4.41%Read full news article

Akums Drugs & Pharmaceuticals Ltd Downgraded to Hold Amid Valuation Concerns Despite Strong Financials

2026-08-14 08:29:48

Akums Drugs & Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold following a comprehensive reassessment of its quality, valuation, financial trend, and technical parameters. While the company’s recent quarterly financial performance has been robust, elevated valuation metrics and mixed technical signals have tempered enthusiasm among analysts, prompting a more cautious stance.

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Buy

2026-08-13 10:11:31

Akums Drugs & Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 775.45

2026-08-12 09:59:01

With a 57.24% gain over the past year, Akums Drugs & Pharmaceuticals Ltd has surged to a fresh 52-week high of Rs 775.45 on 12 Aug 2026, outpacing the Sensex which declined by 2.85% over the same period. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum.

Read full news article

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 760.5

2026-08-11 10:12:06

With a decisive break above Rs 760.5 on 11 Aug 2026, Akums Drugs & Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive rally that has delivered 58.48% returns over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices.

Read full news article

Akums Drugs & Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change

2026-08-11 08:02:48

Akums Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a recalibration of price attractiveness amid robust stock performance and evolving market dynamics.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Surges 7.68% to Day's High of Rs 750 — Outperforms Sector by 7.18 Percentage Points

2026-08-10 11:46:42

The Sensex edged up 0.09% on 10 Aug 2026, but Akums Drugs & Pharmaceuticals Ltd outpaced the broader market with a robust 7.68% gain, reaching an intraday high of Rs 750. This 7.18 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 750

2026-08-10 10:18:31

Surging past its previous peak, Akums Drugs & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 750 on 10 Aug 2026, marking a remarkable 53.0% gain over the past year and outpacing the Sensex’s modest decline of 1.72% during the same period.

Read full news article

When is the next results date for Akums Drugs & Pharmaceuticals Ltd?

2026-08-06 23:20:53

The next results date for Akums Drugs & Pharmaceuticals Ltd is scheduled for August 8, 2026....

Read full news article